For non-MET amplified HCC such as Huh7 tumors, impeding stromal angiogenesis through VEGFR2 inhibition (anti-angiogenesis effect) contributed to the dominant abrogation of tumor growth. Here, MET is linked to hepatocellular carcinoma.